Use of tenofovir-based PrEP among pregnant women in South Africa

The safety of tenofovir-based PrEP during pregnancy is critically important for HIV prevention in South Africa, but real-world data on PrEP use patterns specifically during pregnancy had not been characterized in this population.

Target RWE's HIV team analyzed real-world data from South African women to characterize patterns of tenofovir-based PrEP use during pregnancy, including initiation, continuation, and discontinuation relative to gestational periods.

Documenting real-world PrEP use patterns during pregnancy in high-HIV-incidence South African women provides evidence for HIV prevention program design and adherence interventions targeting pregnant and periconception women.

Tenofovir PrEP utilization characterization during pregnancy in South African women for HIV prevention program design, Real-world PrEP adherence evidence for periconception HIV prevention intervention development